By Josh White
Date: Friday 22 May 2026
(Sharecast News) - RUA Life Sciences said in an update on Friday that it expected to report a smaller EBITDA loss, broadly reaching breakeven on an adjusted basis, after revenue growth in its UK contract development and manufacturing and biomaterials businesses offset weaker trading at Abiss.
| Holding(s) in Company | 02-Jun-2026 | 07:00 | RNS |
| Trading update for the 6-months ended 31/03/2026 | 22-May-2026 | 07:00 | RNS |
| Spinout and Completion of Financing of RSH | 12-May-2026 | 07:00 | RNS |
| Result of AGM | 17-Mar-2026 | 16:54 | RNS |
| AGM Statement and Trading Update | 17-Mar-2026 | 07:00 | RNS |
| Stalemate in legal dispute at AorTech | 30-Sep-2014 | The Herald |
| AIM hopes help Aortech to soar | 25-Nov-2011 | The Herald |
| AorTech surges on supply agreement | 19-May-2009 | The Herald |
| Director Dealings: Archial proves attractive | 13-Apr-2009 | Scotland on Sunday |
| AorTech founders sell shares to board | 07-Apr-2009 | The Herald |
| AorTech leads gainers on latest Scottish StockWa... | 04-Nov-2006 | The Scotsman |
| Smaller stock to watch | 26-Oct-2006 | Times |
| Reeling Plusnet at two-year low as broadband bat... | 08-Aug-2006 | Times |
| Vodafone is ringing a few alarm bells | 21-Jan-2006 | The Scotsman |
| Tomb Raider company takes a hit | 21-Jan-2006 | Guardian |
No recent information was found.
| Currency | UK Pounds |
| Share Price | 17.75p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 25.60 |
| 52 Week Low | 10.50 |
| Volume | 33,317 |
| Shares Issued | 62.06m |
| Market Cap | £11.02m |
| RiskGrade | 290 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 14:11 | 20,831 @ 18.10p |
| 10:09 | 2,486 @ 18.10p |
| 08:02 | 10,000 @ 18.10p |
| CEO | William D Brown |
| CFO | Lachlan Smith |
You are here: research